PuSH - Publikationsserver des Helmholtz Zentrums München

Crystal structure of the RNA-recognition motif of Drosophila melanogaster tRNA (uracil-5-)-methyltransferase homolog A.

Acta Crystallogr. F-Struct. Biol. Cryst. Commun. 80, 36-42 (2024)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Human tRNA (uracil-5-)-methyltransferase 2 homolog A (TRMT2A) is the dedicated enzyme for the methylation of uridine 54 in transfer RNA (tRNA). Human TRMT2A has also been described as a modifier of polyglutamine (polyQ)-derived neuronal toxicity. The corresponding human polyQ pathologies include Huntington's disease and constitute a family of devastating neurodegenerative diseases. A polyQ tract in the corresponding disease-linked protein causes neuronal death and symptoms such as impaired motor function, as well as cognitive impairment. In polyQ disease models, silencing of TRMT2A reduced polyQ-associated cell death and polyQ protein aggregation, suggesting this protein as a valid drug target against this class of disorders. In this paper, the 1.6 Å resolution crystal structure of the RNA-recognition motif (RRM) from Drosophila melanogaster, which is a homolog of human TRMT2A, is described and analysed.
Impact Factor
Scopus SNIP
Altmetric
1.100
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Drosophila Melanogaster ; Rrms ; Trmt2a ; X-ray Crystallography ; Methyltransferases ; Neurodegenerative Disease; Complex Reveals; Binding; Domain; Specificity; Tdp-43; Tool
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
e-ISSN 2053-230X
Quellenangaben Band: 80, Heft: , Seiten: 36-42 Artikelnummer: , Supplement: ,
Verlag Blackwell
Verlagsort Oxford [u.a.]
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503091-001
Förderungen BMBF
Scopus ID 85184139625
PubMed ID 38270511
Erfassungsdatum 2024-04-17